[Bleeding problems of a patient with hypothyroidism].
Paul
Robert
R
AstraZeneca Oy Eteläinen Salmitie 02430 Masala.
D000368:Aged; D000740:Anemia / Q000139:chemically induced; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D004347:Drug Interactions; D004438:Ecchymosis / Q000139:chemically induced; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D007037:Hypothyroidism / Q000150:complications / Q000188:drug therapy; D008551:Melena / Q000139:chemically induced; D008825:Miconazole / Q000009:adverse effects / Q000627:therapeutic use; D013280:Stomatitis / Q000150:complications / Q000188:drug therapy*; D013974:Thyroxine / Q000627:therapeutic use; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D000935:Antifungal Agents; D014859:Warfarin; D008825:Miconazole; D013974:Thyroxine